SCHEMBL6209760

SCHEMBL6209760

NC(=O)CCCC(=O)N1CCC2C1C(=O)CN2S(=O)(=O)C(=O)c1ccccn1

nearest known ligand 0.33

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MT-CO2 P00403 1/20 0.33
ALOX5 P09917 1/20 0.33
RAB9A P51151 2/20 0.32
PKM P14618 1/20 0.32
POLB P06746 1/20 0.32
NAMPT P43490 1/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
SMYD3 Q9H7B4 1/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
HSD17B10 Q99714 1/20 0.32
MEN1 O00255 1/20 0.32
NPC1 O15118 1/20 0.32
KMT2A Q03164 1/20 0.32
DPP4 P27487 2/20 0.31
CCR8 P51685 1/20 0.31
CTNNB1 P35222 2/20 0.31
WNT3A P56704 2/20 0.31
GRM4 Q14833 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6211848 0.91 NAMPT (0.32) MT-CO2ALOX5NAMPTSMYD3L3MBTL1
SCHEMBL4040192 0.86 MT-CO2 (0.31) MT-CO2ALOX5RAB9ASMN1; SMN2SMYD3
SCHEMBL6210237 0.86 DPP4 (0.34) MT-CO2ALOX5POLBDPP4GRM4
SCHEMBL6209393 0.86 CTSL (0.36) SMYD3
SCHEMBL6210331 0.84 L3MBTL1 (0.40) RAB9ANAMPTSMN1; SMN2SMYD3L3MBTL1
SCHEMBL6208713 0.83 PARP1 (0.36) L3MBTL1MEN1KMT2ADPP4
SCHEMBL6208973 0.83 TBXAS1 (0.35) NAMPTL3MBTL1DPP4
SCHEMBL6211186 0.82 KMT2A (0.48) NAMPTSMN1; SMN2MEN1KMT2ADPP4
SCHEMBL6210886 0.80 DPP4 (0.37) NAMPTMEN1KMT2ADPP4
SCHEMBL4042101 0.79 CTSL (0.33) RAB9APKMSMN1; SMN2L3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1546150-A1 BIOLOGICALLY ACTIVE COMPOUNDS Amura Therapeutics Limited (GB) 2005-06-29 EP claimed
WO-2004007501-A1 BIOLOGICALLY ACTIVE COMPOUNDS AMURA THERAPEUTICS LIMITED (GB) 2004-01-22 WO claimed
EP-1546150-A1 BIOLOGICALLY ACTIVE COMPOUNDS Amura Therapeutics Limited (GB) 2005-06-29 EP disclosed
WO-2004007501-A1 BIOLOGICALLY ACTIVE COMPOUNDS AMURA THERAPEUTICS LIMITED (GB) 2004-01-22 WO disclosed